Influence of maternal characteristics and gestational age on hemodynamic indices: NICOM device‐specific reference ranges

  1. Gutierrez, J. 12
  2. Perry, H. 12
  3. Stirrup, O. 3
  4. Vinayagam, D. 12
  5. Thilaganathan, B. 12
  6. Khalil, A. 12
  1. 1 Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute St George's University of London London UK
  2. 2 Fetal Medicine Unit St George's University Hospitals NHS Foundation Trust, University of London London UK
  3. 3 Centre for Clinical Research in Infection and Sexual Health, Institute for Global Health University College London London UK
Mostra les afiliacions +
Revista:
Ultrasound in Obstetrics & Gynecology

ISSN: 0960-7692,  1469-0705

Any de publicació: 2019

Volum: 54

Número: 5

Pàgines: 670-675

Tipus: Article

DOI: 10.1002/UOG.20179 GOOGLE SCHOLAR lock_openAccés obert editor

Altres publicacions en: Ultrasound in Obstetrics & Gynecology

Resum

To construct reference ranges for stroke volume, cardiac output and systemic vascular resistance (SVR) in normal pregnancy for the NICOM® device, andcto explore associations between maternal characteristics and these hemodynamic variables.

€ Mostra el finançament

Informació de finançament

Finançadors

Referències bibliogràfiques

  • Foo FL, Mahendru AA, Masini G, Fraser A, Cacciatore S, MacIntyre DA, McEniery CM, Wilkinson IB, Bennett PR, Lees CC. Association between prepregnancy cardiovascular function and subsequent preeclampsia or fetal growth restrictionnovelty and significance. Hypertension 2018; 72: 442 – 450.
  • Kalafat E, Thilaganathan B. Cardiovascular origins of preeclampsia. Curr Opin Obstet Gynecol 2017; 29: 383 – 389.
  • Vinayagam D, Gutierrez J, Binder J, Mantovani E, Thilaganathan B, Khalil A. Impaired maternal hemodynamics in morbidly obese women: a case– control study. Ultrasound Obstet Gynecol 2017; 50: 761 – 765.
  • Stott D, Nzelu O, Nicolaides KH, Kametas NA. Maternal haemodynamics in normal pregnancies and in pregnancies affected by pre-eclampsia. Ultrasound Obstet Gynecol 2018; 52: 359 – 364.
  • Ferrazzi E, Stampalija T, Monasta L, Di Martino D, Vonck S, Gyselaers W. Maternal hemodynamics: a method to classify hypertensive disorders of pregnancy. Am J Obstet Gynecol 2018; 218: 124.e1– 11.
  • Vinayagam D, Bowe S, Sheehan E, Thilaganathan B, Khalil A. Non-invasive haemodynamic monitoring in pregnancy: a comparative study using ultrasound and bioreactance. Fetal Diagn Ther 2017; 41: 273 – 282.
  • Vinayagam D, Patey O, Thilaganathan B, Khalil A. Cardiac output assessment in pregnancy: comparison of two automated monitors with echocardiography. Ultrasound Obstet Gynecol 2017; 49: 32 – 38.
  • Gutierrez J, Perry H, Columb MO, Vinayagam D, Bampoe S, Thilaganathan B, Khalil A. Cardiac output measurements during high-risk Cesarean section using electrical bioreactance or arterial wave form analysis: an assessment of agreement. Ultrasound Obstet Gynecol 2019; 54: 232 – 238.
  • Vinayagam D, Thilaganathan B, Stirrup O, Mantovani E, Khalil A. Maternal hemodynamics in normal pregnancies: reference ranges and the role of maternal characteristics. Ultrasound Obstet Gynecol 2018; 51: 665 – 671.
  • Robinson HP, Fleming JE. A critical evaluation of sonar ‘‘crown-rump length’’ measurements. Br J Obstet Gynaecol 1975; 82: 702 – 710.
  • Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, Zeeman GG, Brown MA. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens 2014; 4: 97 – 104.
  • Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, Silver RM, Wynia K, Ganzevoort W. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol 2016; 48: 333 – 339.
  • Stasinopoulos D, Rigby R. Generalized Additive Models for Location Scale and Shape (GAMLSS) in R. J Stat Softw 2008; 23: DOI: 10.18637/jss.v023.i07.
  • Rigby RA, Stasinopoulos DM. Smooth centile curves for skew and kurtotic data modelled using the Box– Cox power exponential distribution. Stat Med 2004; 23: 3053 – 3076.
  • Meah VL, Cockcroft JR, Backx K, Shave R, Sto¨ hr EJ. Cardiac output and related hae- modynamics during pregnancy: a series of meta-analyses. Heart 2016; 102: 518 – 526.
  • Mahendru AA, Everett TR, Wilkinson IB, Lees CC, McEniery CM. A longitudinal study of maternal cardiovascular function from preconception to the postpartum period. J Hypertens 2014; 32: 849 – 856.
  • Monteith C, McSweeney L, Breatnach CR, Doherty A, Shirren L, Tully EC, Dicker P, Malone FD, EL-Khuffash A, Kent E. Non-invasive cardiac output monitoring (NICOM) can predict the evolution of uteroplacental disease — Results of the prospective HANDLE study. Eur J Obstet Gynecol Reprod Biol 2017; 216: 116 – 124.
  • Tay J, Foo L, Masini G, Bennett PR, Mceniery CM, Wilkinson IB, Lees CC. Cardiac output in pre eclampsia is associated with the presence of fetal growth restriction, not gestation at onset: A prospective cohort study. Am J Obstet Gynecol 2018; 218: 517.e1– 12.
  • Guy GP, Ling HZ, Garcia P, Poon LC, Nicolaides KH. Maternal cardiac function at 35 – 37 weeks’ gestation: prediction of pre-eclampsia and gestational hypertension. Ultrasound Obstet Gynecol 2017; 49: 61 – 66.
  • Verlohren S, Perschel FH, Thilaganathan B, Dro¨ ge LA, Henrich W, Busjahn A, Khalil A. Angiogenic markers and cardiovascular indices in the prediction of hypertensive disorders of pregnancy. Hypertension 2017; 69: 1192 – 1197.
  • Stott D, Bolten M, Paraschiv D, Papastefanou I, Chambers JB, Kametas NA. Longitudinal hemodynamics in acute phase of treatment with labetalol in hypertensive pregnant women to predict need for vasodilatory therapy. Ultrasound Obstet Gynecol 2017; 49: 85 – 94.
  • Behrens I, Basit S, Melbye M, Lykke JA, Wohlfahrt J, Bundgaard H, Thilaganathan B, Boyd HA. Risk of post-pregnancy hypertension in women with a history of hyper- tensive disorders of pregnancy: nationwide cohort study. BMJ 2017; 358: j3078.
  • Veerbeek JHW, Hermes W, Breimer AY, van Rijn BB, Koenen S V., Mol BW, Franx A, de Groot CJM, Koster MPH. Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertensionnovelty and significance. Hypertension 2015; 65: 600 – 606.
  • Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension 2010; 56: 166 – 171.
  • Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension 2011; 58: 709 – 715.